+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Heart Attack Diagnostics Market By Type: Global Opportunity Analysis and Industry Forecast, 2024-2033- Product Image
Heart Attack Diagnostics Market By Type: Global Opportunity Analysis and Industry Forecast, 2024-2033- Product Image
Sale

Heart Attack Diagnostics Market By Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 260 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5993966
UP TO OFF until Nov 15th 2024
Description Jump to:
The heart attack diagnostics market was valued at $9.2 billion in 2023 and is projected to reach $21.1 billion by 2033, growing at a CAGR of 8.6% from 2024 to 2033.

Heart attack diagnostic comprises of diagnosing the blood pressure, temperature, and pulse rate of a patient. A series of evaluations are conducted to determine if an individual has experienced a heart attack, also known as myocardial infarction. The series of diagnostic tests includes an electrocardiogram (EKG) which measures the electrical activity of heart, blood tests to detect cardiac enzymes such as troponin which are released into the bloodstream in case of heart muscle damage, and imaging tests such as coronary angiography or echocardiography for the visualization of heart & its blood vessels.

Increase in sedentary lifestyles has led to surge in occurrence of lifestyle diseases, including heart attack. This has led to surge in demand for heart attack diagnostics, hence augmenting the growth of the market. Furthermore, exponential growth in the geriatric population globally is opening avenues for the expansion of the market. The assimilation of AI in the EKG testing is poised to become mainstream in the future as it reduces the diagnosis time. A hospital in Taiwan conducted research regarding the assimilation of AI and EKG, which reduced the diagnosis period by 10 minutes. Constant improvements in AI are enhancing the efficacy of clinical decision support system, encouraging medical practitioners to adopt the technology.

However, these diagnostics tests are extremely expensive and prevent several end users from leveraging their benefits, hence restraining the market development. In addition, the introduction of new diagnostic technologies is subject to various regulatory hurdles, hence presenting challenges for the expansion of the market. Different regulatory bodies such as the U.S. Food and Drug Administration, European Medicines Agency, the Pharmaceuticals and Medical Devices Agency in Japan, and Central Drugs Standard Control Organization in India have mandated the adherence to their respective regulatory guidelines for the entry of new diagnostic technologies into the market. Contrarily, innovative techniques being introduced into the market are an indicator of its promising future. For instance, Siemens Healthineers, a German healthcare company, has introduced a handheld device which claims to detect heart attack in less than 30 minutes. The launch of such devices is expected to quicken treatment delivery and increase the chances of recovery for patients in the future.

Segment Review

The heart attack diagnostics market is segmented into type, end user, and region. On the basis of type, the market is divided into electrocardiogram, blood tests, angiogram, computerized cardiac tomography, and others. By end user, it is classified into hospitals, diagnostics centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competition Analysis

The major players operating in the global heart attack diagnostics market include Bionet Co., Ltd, TOSHIBA CORPORATION, Bio-Rad Laboratories Inc, Life Sign LLC, Schiller AG, Beckman Coulter,Inc., GE Healthcare, Hitachi Medical Systems, F. Hoffmann-La Roche Ltd., and Abbott Laboratories. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Electrocardiogram
  • Blood Tests
  • Angiogram
  • Computerized Cardiac Tomography
  • Others

By End User

  • Hospitals
  • Diagnostics Centers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA
Key Market Players
  • Bionet Co., Ltd
  • TOSHIBA CORPORATION
  • Bio-Rad Laboratories Inc
  • Life Sign LLC
  • Schiller AG
  • Beckman Coulter,Inc.
  • GE Healthcare
  • Hitachi Medical Systems
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4: HEART ATTACK DIAGNOSTICS MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Electrocardiogram
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Blood Tests
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Angiogram
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Computerized Cardiac Tomography
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Others
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
CHAPTER 5: HEART ATTACK DIAGNOSTICS MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Diagnostics Centers
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: HEART ATTACK DIAGNOSTICS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Type
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Heart Attack Diagnostics Market
6.2.5.1. Market Size and Forecast, By Type
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Heart Attack Diagnostics Market
6.2.6.1. Market Size and Forecast, By Type
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Heart Attack Diagnostics Market
6.2.7.1. Market Size and Forecast, By Type
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Type
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. France Heart Attack Diagnostics Market
6.3.5.1. Market Size and Forecast, By Type
6.3.5.2. Market Size and Forecast, By End User
6.3.6. Germany Heart Attack Diagnostics Market
6.3.6.1. Market Size and Forecast, By Type
6.3.6.2. Market Size and Forecast, By End User
6.3.7. Italy Heart Attack Diagnostics Market
6.3.7.1. Market Size and Forecast, By Type
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Spain Heart Attack Diagnostics Market
6.3.8.1. Market Size and Forecast, By Type
6.3.8.2. Market Size and Forecast, By End User
6.3.9. UK Heart Attack Diagnostics Market
6.3.9.1. Market Size and Forecast, By Type
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest of Europe Heart Attack Diagnostics Market
6.3.10.1. Market Size and Forecast, By Type
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Type
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. China Heart Attack Diagnostics Market
6.4.5.1. Market Size and Forecast, By Type
6.4.5.2. Market Size and Forecast, By End User
6.4.6. Japan Heart Attack Diagnostics Market
6.4.6.1. Market Size and Forecast, By Type
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Heart Attack Diagnostics Market
6.4.7.1. Market Size and Forecast, By Type
6.4.7.2. Market Size and Forecast, By End User
6.4.8. South Korea Heart Attack Diagnostics Market
6.4.8.1. Market Size and Forecast, By Type
6.4.8.2. Market Size and Forecast, By End User
6.4.9. Australia Heart Attack Diagnostics Market
6.4.9.1. Market Size and Forecast, By Type
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Heart Attack Diagnostics Market
6.4.10.1. Market Size and Forecast, By Type
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Type
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Heart Attack Diagnostics Market
6.5.5.1. Market Size and Forecast, By Type
6.5.5.2. Market Size and Forecast, By End User
6.5.6. South Africa Heart Attack Diagnostics Market
6.5.6.1. Market Size and Forecast, By Type
6.5.6.2. Market Size and Forecast, By End User
6.5.7. Saudi Arabia Heart Attack Diagnostics Market
6.5.7.1. Market Size and Forecast, By Type
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Heart Attack Diagnostics Market
6.5.8.1. Market Size and Forecast, By Type
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Bionet Co., Ltd
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. TOSHIBA CORPORATION
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Bio-Rad Laboratories Inc
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Life Sign LLC
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Schiller AG
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Beckman Coulter, Inc.
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. GE Healthcare
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Hitachi Medical Systems
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. F. Hoffmann-La Roche Ltd.
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Abbott Laboratories
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Heart Attack Diagnostics Market, by Type, 2024 - 2033 ($Billion)
Table 2. Heart Attack Diagnostics Market for Electrocardiogram, by Region, 2024 - 2033 ($Billion)
Table 3. Heart Attack Diagnostics Market for Blood Tests, by Region, 2024 - 2033 ($Billion)
Table 4. Heart Attack Diagnostics Market for Angiogram, by Region, 2024 - 2033 ($Billion)
Table 5. Heart Attack Diagnostics Market for Computerized Cardiac Tomography, by Region, 2024 - 2033 ($Billion)
Table 6. Heart Attack Diagnostics Market for Others, by Region, 2024 - 2033 ($Billion)
Table 7. Global Heart Attack Diagnostics Market, by End-user, 2024 - 2033 ($Billion)
Table 8. Heart Attack Diagnostics Market for Hospitals, by Region, 2024 - 2033 ($Billion)
Table 9. Heart Attack Diagnostics Market for Diagnostics Centers, by Region, 2024 - 2033 ($Billion)
Table 10. Heart Attack Diagnostics Market for Others, by Region, 2024 - 2033 ($Billion)
Table 11. Heart Attack Diagnostics Market, by Region, 2024 - 2033 ($Billion)
Table 12. North America Heart Attack Diagnostics, by Country, 2024 - 2033 ($Billion)
Table 13. North America Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 14. North America Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 15. U.S. Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 16. U.S. Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 17. Canada Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 18. Canada Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 19. Mexico Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 20. Mexico Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 21. Europe Heart Attack Diagnostics, by Country, 2024 - 2033 ($Billion)
Table 22. Europe Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 23. Europe Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 24. France Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 25. France Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 26. Germany Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 27. Germany Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 28. Italy Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 29. Italy Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 30. Spain Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 31. Spain Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 32. UK Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 33. UK Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 34. Rest of Europe Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 35. Rest of Europe Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 36. Asia-Pacific Heart Attack Diagnostics, by Country, 2024 - 2033 ($Billion)
Table 37. Asia-Pacific Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 38. Asia-Pacific Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 39. China Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 40. China Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 41. Japan Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 42. Japan Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 43. India Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 44. India Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 45. South Korea Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 46. South Korea Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 47. Australia Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 48. Australia Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 49. Rest of Asia-Pacific Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 50. Rest of Asia-Pacific Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 51. LAMEA Heart Attack Diagnostics, by Country, 2024 - 2033 ($Billion)
Table 52. LAMEA Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 53. LAMEA Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 54. Brazil Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 55. Brazil Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 56. South Africa Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 57. South Africa Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 58. Saudi Arabia Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 59. Saudi Arabia Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 60. Rest of LAMEA Heart Attack Diagnostics, by Type, 2024 - 2033 ($Billion)
Table 61. Rest of LAMEA Heart Attack Diagnostics, by End-user, 2024 - 2033 ($Billion)
Table 62. Bionet Co. Ltd.: Key Executives
Table 63. Bionet Co. Ltd.: Company Snapshot
Table 64. Bionet Co. Ltd.: Operating Segments
Table 65. Bionet Co. Ltd.: Product Portfolio
Table 66. Bionet Co. Ltd.: Key Strategic Moves and Developments
Table 67. Toshiba Corporation: Key Executives
Table 68. Toshiba Corporation: Company Snapshot
Table 69. Toshiba Corporation: Operating Segments
Table 70. Toshiba Corporation: Product Portfolio
Table 71. Toshiba Corporation: Key Strategic Moves and Developments
Table 72. Bio-Rad Laboratories Inc.: Key Executives
Table 73. Bio-Rad Laboratories Inc.: Company Snapshot
Table 74. Bio-Rad Laboratories Inc.: Operating Segments
Table 75. Bio-Rad Laboratories Inc.: Product Portfolio
Table 76. Bio-Rad Laboratories Inc.: Key Strategic Moves and Developments
Table 77. Life Sign LLC: Key Executives
Table 78. Life Sign LLC: Company Snapshot
Table 79. Life Sign LLC: Operating Segments
Table 80. Life Sign LLC: Product Portfolio
Table 81. Life Sign LLC: Key Strategic Moves and Developments
Table 82. Schiller AG: Key Executives
Table 83. Schiller AG: Company Snapshot
Table 84. Schiller AG: Operating Segments
Table 85. Schiller AG: Product Portfolio
Table 86. Schiller AG: Key Strategic Moves and Developments
Table 87. Beckman Coulter, Inc.: Key Executives
Table 88. Beckman Coulter, Inc.: Company Snapshot
Table 89. Beckman Coulter, Inc.: Operating Segments
Table 90. Beckman Coulter, Inc.: Product Portfolio
Table 91. Beckman Coulter, Inc.: Key Strategic Moves and Developments
Table 92. GE Healthcare: Key Executives
Table 93. GE Healthcare: Company Snapshot
Table 94. GE Healthcare: Operating Segments
Table 95. GE Healthcare: Product Portfolio
Table 96. GE Healthcare: Key Strategic Moves and Developments
Table 97. Hitachi Medical Systems: Key Executives
Table 98. Hitachi Medical Systems: Company Snapshot
Table 99. Hitachi Medical Systems: Operating Segments
Table 100. Hitachi Medical Systems: Product Portfolio
Table 101. Hitachi Medical Systems: Key Strategic Moves and Developments
Table 102. F. Hoffmann-La Roche Ltd.: Key Executives
Table 103. F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 104. F. Hoffmann-La Roche Ltd.: Operating Segments
Table 105. F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 106. F. Hoffmann-La Roche Ltd.: Key Strategic Moves and Developments
Table 107. Abbott Laboratories: Key Executives
Table 108. Abbott Laboratories: Company Snapshot
Table 109. Abbott Laboratories: Operating Segments
Table 110. Abbott Laboratories: Product Portfolio
Table 111. Abbott Laboratories: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Heart Attack Diagnostics Market Segmentation
Figure 2. Global Heart Attack Diagnostics Market
Figure 3. Segmentation Heart Attack Diagnostics Market
Figure 4. Top Investment Pocket in Heart Attack Diagnostics Market
Figure 5. Moderate Bargaining Power of Buyers
Figure 6. Moderate Bargaining Power of Suppliers
Figure 7. Moderate Threat of New Entrants
Figure 8. Low Threat of Substitution
Figure 9. High Competitive Rivalry
Figure 10. Opportunities, Restraints and Drivers: Globalheart Attack Diagnostics Market
Figure 11. Global Heart Attack Diagnostics Market Segmentation, by Type
Figure 12. Heart Attack Diagnostics Market for Electrocardiogram, by Country, 2024 - 2033 ($Billion)
Figure 13. Heart Attack Diagnostics Market for Blood Tests, by Country, 2024 - 2033 ($Billion)
Figure 14. Heart Attack Diagnostics Market for Angiogram, by Country, 2024 - 2033 ($Billion)
Figure 15. Heart Attack Diagnostics Market for Computerized Cardiac Tomography, by Country, 2024 - 2033 ($Billion)
Figure 16. Heart Attack Diagnostics Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 17. Global Heart Attack Diagnostics Market Segmentation, by End-user
Figure 18. Heart Attack Diagnostics Market for Hospitals, by Country, 2024 - 2033 ($Billion)
Figure 19. Heart Attack Diagnostics Market for Diagnostics Centers, by Country, 2024 - 2033 ($Billion)
Figure 20. Heart Attack Diagnostics Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 21. Top Winning Strategies, by Year, 2021-2023*
Figure 22. Top Winning Strategies, by Development, 2021-2023*
Figure 23. Top Winning Strategies, by Company, 2021-2023*
Figure 24. Product Mapping of Top 10 Players
Figure 25. Competitive Dashboard
Figure 26. Competitive Heatmap: Heart Attack Diagnostics Market
Figure 27. Top Player Positioning, 2023
Figure 28. Bionet Co. Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 29. Bionet Co. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 30. Bionet Co. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 31. Toshiba Corporation: Net Sales, 2021-2023 ($Billion)
Figure 32. Toshiba Corporation: Revenue Share, by Segment, 2023 (%)
Figure 33. Toshiba Corporation: Revenue Share, by Region, 2023 (%)
Figure 34. Bio-Rad Laboratories Inc.: Net Sales, 2021-2023 ($Billion)
Figure 35. Bio-Rad Laboratories Inc.: Revenue Share, by Segment, 2023 (%)
Figure 36. Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2023 (%)
Figure 37. Life Sign LLC: Net Sales, 2021-2023 ($Billion)
Figure 38. Life Sign LLC: Revenue Share, by Segment, 2023 (%)
Figure 39. Life Sign LLC: Revenue Share, by Region, 2023 (%)
Figure 40. Schiller AG: Net Sales, 2021-2023 ($Billion)
Figure 41. Schiller AG: Revenue Share, by Segment, 2023 (%)
Figure 42. Schiller AG: Revenue Share, by Region, 2023 (%)
Figure 43. Beckman Coulter, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 44. Beckman Coulter, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 45. Beckman Coulter, Inc.: Revenue Share, by Region, 2023 (%)
Figure 46. GE Healthcare: Net Sales, 2021-2023 ($Billion)
Figure 47. GE Healthcare: Revenue Share, by Segment, 2023 (%)
Figure 48. GE Healthcare: Revenue Share, by Region, 2023 (%)
Figure 49. Hitachi Medical Systems: Net Sales, 2021-2023 ($Billion)
Figure 50. Hitachi Medical Systems: Revenue Share, by Segment, 2023 (%)
Figure 51. Hitachi Medical Systems: Revenue Share, by Region, 2023 (%)
Figure 52. F. Hoffmann-La Roche Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 53. F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 54. F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2023 (%)
Figure 55. Abbott Laboratories: Net Sales, 2021-2023 ($Billion)
Figure 56. Abbott Laboratories: Revenue Share, by Segment, 2023 (%)
Figure 57. Abbott Laboratories: Revenue Share, by Region, 2023 (%)

Companies Mentioned

Key Market Players in the Heart Attack Diagnostics Market include:
  • Bionet Co., Ltd
  • TOSHIBA CORPORATION
  • Bio-Rad Laboratories Inc
  • Life Sign LLC
  • Schiller AG
  • Beckman Coulter,Inc.
  • GE Healthcare
  • Hitachi Medical Systems
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages260
PublishedJuly 2024
Forecast Period2023 - 2033
Estimated Market Value ( USD ) in 2023 $ 9.2 billion
Forecasted Market Value ( USD ) by 2033 $ 21.1 billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Heart Attack Diagnostic Global Market Report 2024 - Product Image

Heart Attack Diagnostic Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Diagnostic Electrocardiograph Market Report 2024 - Product Image

Diagnostic Electrocardiograph Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Heart Attack Diagnostics Market by Test, End User - Global Forecast 2025-2030 - Product Image

Heart Attack Diagnostics Market by Test, End User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Heart Attack Diagnostics Market Size, Share & Trends Analysis Report By Test (Electrocardiogram, Blood Test), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Heart Attack Diagnostics Market Size, Share & Trends Analysis Report By Test (Electrocardiogram, Blood Test), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Metabolic Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Metabolic Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.